Pupil check to predict CAR-T brain side effects
Part of Brain & nervous system clinical trials.
This study tests if checking your pupil size with a small light device can predict brain-related side effects from CAR-T cell therapy. It is for patients with certain lymphomas receiving axi-cel CAR-T treatment in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a type of large B-cell lymphoma (DLBCL, PMBCL, or transformed follicular lymphoma) and are scheduled to receive a CAR-T cell therapy called axi-cel in the hospital.
- You are willing to sign a consent form to participate.
- You have not received CAR-T cell therapy before.
- You are willing and able to have your pupil size measured with a small device called a pupillometer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a quick iPad tool to check for thinking or memory problems that can happen after CAR-T cell therapy. It may help find early signs of brain-related side effects.
This study uses blood tests and brain imaging to better understand and predict nerve-system side effects that can happen after CAR T-cell treatment. It may help doctors spot people at higher risk sooner and guide safer care.
This study looks at how thinking and brain function change over time in people with lymphoma who receive CAR T therapy. It may help doctors understand side effects and better support patients during and after treatment.
This trial looks at how CAR-T treatment affects the brain and thinking skills. It aims to better understand and help with side effects like confusion or memory problems.
This Phase 1 study tests a new type of immune therapy (CAR T cells) placed directly into the fluid around the brain to treat central nervous system (CNS) lymphoma. It mainly looks at safety and how well the treatment can control the lymphoma when other CNS treatments have not worked.
This study looks at how CAR-T cell therapy for certain types of lymphoma may affect thinking and memory. It helps doctors understand and support patients' brain health during treatment.
Hear when a new Neurotoxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.